EC Number |
IC50 Value |
IC50 Value Maximum |
Inhibitor |
Reference |
---|
3.4.14.5 | -999 |
- |
alogliptin |
50% inhibition of DPP-4 activity is observed at an alogliptin plasma concentration of 3.7 ng/ml |
697436 |
3.4.14.5 | 0.0000000003 |
- |
(2S)-2-(4-[[([(4R)-3-[(3R)-3-amino-4-(2,5-difluorophenyl)butanoyl]-1,3-thiazolidin-4-yl]carbonyl)amino]methyl]phenyl)-3-methylbutanoic acid |
- |
681506 |
3.4.14.5 | 0.00000000048 |
- |
(2S)-2-[4-[([1-[(3S)-3-amino-4-(2,5-difluorophenyl)butanoyl]-L-prolyl]amino)methyl]phenoxy]-3-methylbutanoic acid |
- |
681506 |
3.4.14.5 | 0.00000000083 |
- |
(2S)-2-(4-[[(1-[(3S)-3-amino-4-[2-fluoro-4-(trifluoromethyl)phenyl]butanoyl]-L-prolyl)amino]methyl]phenoxy)-3-methylbutanoic acid |
- |
681506 |
3.4.14.5 | 0.0000000016 |
- |
(2S)-2-[4-[([1-[(3S)-3-amino-4-(3,4-difluorophenyl)butanoyl]-L-prolyl]amino)methyl]phenoxy]-3-methylbutanoic acid |
- |
681506 |
3.4.14.5 | 0.0000000016 |
- |
(2S)-2-[4-[([1-[(3S)-3-amino-4-(5-chloro-2-fluorophenyl)butanoyl]-L-prolyl]amino)methyl]phenoxy]-3-methylbutanoic acid |
- |
681506 |
3.4.14.5 | 0.0000000017 |
- |
(2S)-2-[4-[([1-[(3S)-3-amino-4-(2-chloro-4-fluorophenyl)butanoyl]-L-prolyl]amino)methyl]phenoxy]-3-methylbutanoic acid |
- |
681506 |
3.4.14.5 | 0.0000000018 |
- |
(2S)-2-[4-[([1-[(3S)-3-amino-4-(2-fluorophenyl)butanoyl]-L-prolyl]amino)methyl]phenoxy]-3-methylbutanoic acid |
- |
681506 |
3.4.14.5 | 0.0000000022 |
- |
(2S,3S)-3-amino-4-[(3S)-3-fluoropyrrolidin-1-yl]-N,N-dimethyl-4-oxo-2-[3'-(2H-tetrazol-2-yl)biphenyl-4-yl]butanamide |
- |
681506 |
3.4.14.5 | 0.000000003 |
- |
3-(4'-[(1S,2S)-2-amino-3-[(3S)-3-fluoropyrrolidin-1-yl]-1-methyl-3-oxopropyl]biphenyl-3-yl)-1,2,4-oxadiazolidin-5-one |
- |
681506 |